Synthesis of β-amyloid fragment 5rhdsgy10 and its isomers with the use of new solid-phase peptide synthesis schedule

   


1. Orekhovich Institute of Biomedical Chemistry, Russian Аcademy of Medical Sciences
Type: Experimental/clinical study
UDK: 577.112.6      PubMed Id: 18522220
Year: 2008 vol: 54  issue:2  pages: 184-191
Abstract: Peptide RHDSGY that represents the fragment of human β-amyloid Zn-binding site and its isomers RH(D-Asp)SGY and RH(β-Asp)SGY have been prepared by solid-phase synthesis and analysed by HPLC and various mass-spectrometric methods. The problem of low yield of peptide RHDSGY and its isomers attributed to 9-fluorenylmethoxycarbonyl (Fmoc)-amino acids and/or formation of side-products as RH(Asp-imide)SGY and RHDSGY (instead of RH(β-Asp)SGY) was solved via selection of reagents for the removal of Fmoc groups from the growing peptide chain.
Download PDF:
Reference: Aleshina E.Yu., Pyndyk N.V., Moisa A.A., Sanzhakov M.A., Kharybin O.N., Nikolaev E.N., Kolesanova E.F., Synthesis of β-amyloid fragment 5rhdsgy10 and its isomers with the use of new solid-phase peptide synthesis schedule, Biomeditsinskaya khimiya, 2008, vol: 54(2), 184-191.
Bibliography
 2016(Vol:62)
 2015(Vol:61)
 2014(Vol:60)
 2013(Vol:59)
 2012(Vol:58)
 2011(Vol:57)
 2010(Vol:56)
 2009(Vol:55)
 2008(Vol:54)
 2007(Vol:53)
 2006(Vol:52)
 2005(Vol:51)
 2004(Vol:50)
 2003(Vol:49)